Prosecution Insights
Last updated: May 29, 2026

Xygenyx Inc.

10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready

Portfolio Summary

10
Total Pending OAs
5
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
9
Medium (90%)
0
Easy (0%)
1
Unknown (10%)

Rejection Statute Mix

BucketCases
§103 only8 (80%)
§102 only1 (10%)
No statute on record1 (10%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TIEN, LUCY MINYU 1 61.3% +35.6%
RAO, PADMAJA S 1 69.5% +35.9%
LAZARO, DOMINIC 1 63.1% +31.3%
VARADARAJ, ARCHANA 1 100.0% +0.0%
BUNNER, BRIDGET E 1 64.4% +19.7%
BENAVIDES, JENNIFER ANN 1 50.0% +44.9%
ALAM, AYAAN A 1 36.6% +35.8%
KETCHAM, KAREN A 1 19.6% +36.1%
PARK, HAEJIN S 1 55.3% +37.9%
BRADLEY, CHRISTINA 1 62.7% +33.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18299620 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION VARADARAJ, ARCHANA 26d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18297535 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION KETCHAM, KAREN A 70d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18116849 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 296d overdue
18297841 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION ALAM, AYAAN A 14d
18299480 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BUNNER, BRIDGET E 21d
18299453 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BENAVIDES, JENNIFER ANN 26d
18295181 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION PARK, HAEJIN S 34d
18329491 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION RAO, PADMAJA S 40d
18329496 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION TIEN, LUCY MINYU 70d
18297535 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION KETCHAM, KAREN A 70d

Top Art Units

Art UnitApps
1611 2
1614 2
1612 1
1627 1
1658 1
1647 1
1675 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18329496 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION TIEN, LUCY MINYU 1612 §103 Final Rejection 70d Pending Jun 05, 2023
18329491 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION RAO, PADMAJA S 1627 Other Non-Final OA 40d Pending Jun 05, 2023
18299716 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION LAZARO, DOMINIC 1611 §103 Final Rejection 84d Pending Apr 13, 2023
18299620 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION VARADARAJ, ARCHANA 1658 §103 Non-Final OA 26d Pending Apr 12, 2023
18299480 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BUNNER, BRIDGET E 1647 §102 Non-Final OA 21d Pending Apr 12, 2023
18299453 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BENAVIDES, JENNIFER ANN 1675 §103 Non-Final OA 26d Pending Apr 12, 2023
18297841 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION ALAM, AYAAN A 1611 §103 Final Rejection 14d Pending Apr 10, 2023
18297535 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION KETCHAM, KAREN A 1614 §103 Final Rejection 70d Pending Apr 07, 2023
18295181 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION PARK, HAEJIN S 1614 §103 Non-Final OA 34d Pending Apr 03, 2023
18116849 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 1654 §103 Final Rejection 296d overdue Pending Mar 03, 2023

Managing Xygenyx Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month